Olema Oncology partners with Pfizer for breast cancer drug trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St climbs after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Olema Pharmaceuticals (OLMA) latest collaboration could create future 'bidding war' - Oppenheimer
September 3, 2025 3:01 PM EDTOppenheimer analyst Matthew Biegler reiterated an Outperform rating and $22.00 price target on Olema Pharmaceuticals (NASDAQ: OLMA), saying the Pfizer collaboration could lead to a future bidding war for the company.
The analyst commented, "We had a chance to speak with Olema management after... More
